The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel

Biomaterials

Volumn 33, Issue 8, 2012, Pages 2508-2520

  Zhao, Bing Xiang ^a   Zhao, Yang ^a   Huang, Yue ^a   Luo, Lin Min ^a   Song, Ping ^a   Wang, Xin ^a   Chen, Su ^a   Yu, Ke Fu ^a   Zhang, Xuan ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Anti Tumor efficacy; PH responsive peptide; Polymeric micelles; Targeting; Tumor pH

Indexed keywords

ACIDIC PH; ADENOCARCINOMA CELLS; ANTI-ANGIOGENIC ACTIVITY; ANTI-TUMOR ACTIVITIES; ANTI-TUMOR EFFICACY; ANTI-TUMORS; BIODISTRIBUTIONS; HUMAN BREAST; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HYDRATION METHOD; IN-VITRO; IN-VIVO; PACLITAXEL; PH-RESPONSIVE; POLYMERIC MICELLE; SOLID TUMORS; TARGETING; TUMOR CELLS; TUMOR TISSUES;

CONFOCAL MICROSCOPY; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HISTOLOGY; MAMMALS; MICELLES; PEPTIDES; POLYMERS;

TUMORS;

DRUG CARRIER; PACLITAXEL; PEPTIDE; PEPTIDE MODIFIED POLYMERIC MICELLE; POLYMER; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER TISSUE; CELL STRAIN MCF 7; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; DRUG SCREENING; DRUG TARGETING; ENCAPSULATION; ENDOTHELIUM CELL; FEMALE; FILM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN MODIFICATION; TUMOR CELL; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CARBOCYANINES; CELL LINE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MICE, INBRED BALB C; MICELLES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVESSELS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; PARTICLE SIZE; PEPTIDES; POLYMERS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84855822879     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.078     Document Type: Article

References (51)

1. Oerlemans C., Bult W., Bos M., Storm G., Nijsen J.F., Hennink W.E. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res 2010, 27(12):2569-2589.
2. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001, 47(1):113-131.
3. Adams M.L., Lavasanifar A., Kwon G.S. Amphiphilic block copolymers for drug delivery. JPharm Sci 2003, 92(7):1343-1355.
4. Lavasanifar A., Samuel J., Kwon G.S. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002, 54(2):169-190.
5. Talelli M., Iman M., Varkouhi A.K., Rijcken C.J., Schiffelers R.M., Etrych T., et al. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials 2010, 31(30):7797-7804.
6. Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. JDrug Target 2007, 15(7-8):457-464.
7. Bae Y., Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliv Rev 2009, 61(10):768-784.
8. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006, 6(9):688-701.
9. Parker N., Turk M.J., Westrick E., Lewis J.D., Low P.S., Leamon C.P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 2005, 338(2):284-293.
10. Lee E.S., Gao Z., Bae Y.H. Recent progress in tumor pH targeting nanotechnology. JControl Release 2008, 132(3):164-170.
11. Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989, 49(16):4373-4384.
12. Engin K., Leeper D.B., Cater J.R., Thistlethwaite A.J., Tupchong L., McFarlane J.D. Extracellular pH distribution in human tumours. Int J Hyperthermia 1995, 11(2):211-216.
13. Felber A.E., Dufresne M.H., Leroux J.C. pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 2011, PMID: 21996056.
14. Sethuraman V.A., Bae Y.H. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. JControl Release 2007, 118(2):216-224.
15. Sethuraman V.A., Lee M.C., Bae Y.H. Abiodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res 2008, 25(3):657-666.
16. Foged C., Nielsen H.M. Cell-penetrating peptides for drug delivery across membrane barriers. Expert Opin Drug Deliv 2008, 5(1):105-117.
17. Rousselle C., Clair P., Lefauconnier J.M., Kaczorek M., Scherrmann J.M., Temsamani J. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol 2000, 57(4):679-686.
18. Ruan G., Agrawal A., Marcus A.I., Nie S. Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. JAm Chem Soc 2007, 129(47):14759-14766.
19. Said Hassane F., Saleh A.F., Abes R., Gait M.J., Lebleu B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci 2010, 67(5):715-726.
20. Meade B.R., Dowdy S.F. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev 2007, 59(2-3):134-140.
21. Torchilin V.P., Rammohan R., Weissig V., Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 2001, 98(15):8786-8791.
22. Torchilin V.P. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 2008, 90(5):604-610.
23. Vivès E., Richard J.P., Rispal C., Lebleu B. TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci 2003, 4(2):125-132.
24. Kaplan I.M., Wadia J.S., Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. JControl Release 2005, 102(1):247-253.
25. Lee E.S., Gao Z., Kim D., Park K., Kwon I.C., Bae Y.H. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. JControl Release 2008, 129(3):228-236.
26. Huang Y., Chen X.M., Zhao B.X., Ke X.Y., Zhao B.J., Zhao X., et al. Antiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): invitro and invivo. AAPS PharmSciTech 2010, 11(2):752-759.
27. Zhao B.J., Ke X.Y., Huang Y., Chen X.M., Zhao X., Zhao B.X., et al. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats. JDrug Target 2011, 19(5):382-390.
28. Liu X.R., Wu K.C., Huang Y., Sun J.B., Ke X.Y., Wang J.C., et al. Invitro and invivo studies on plasma-to-blood ratio of paclitaxel in human, rabbit and rat blood fractions. Biol Pharm Bull 2008, 31(6):1215-1220.
29. Futaki S., Nakase I., Suzuki T., Youjun Z., Sugiura Y. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 2002, 41(25):7925-7930.
30. Lee E.S., Shin H.J., Na K., Bae Y.H. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. JControl Release 2003, 90(3):363-374.
31. Lee E.S., Na K., Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. JControl Release 2003, 91(1-2):103-113.
32. Lee E.S., Na K., Bae Y.H. Super pH-sensitive multifunctional polymeric micelle. Nano Lett 2005, 5(2):325-329.
33. Kim G.M., Bae Y.H., Jo W.H. pH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media. Macromol Biosci 2005, 5(11):1118-1124.
34. Gao Z.G., Lee D.H., Kim D.I., Bae Y.H. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. JDrug Target 2005, 13(7):391-397.
35. Futaki S., Ishikawa T., Niwa M., Kitagawa K., Yagami T. Embodying a stable alpha-helical protein structure through efficient chemical ligation via thioether formation. Bioorg Med Chem 1997, 5(9):1883-1891.
36. Pan J.G., Mak T.W. Metabolic targeting as an anticancer strategy: dawn of a new era?. Sci STKE 2007, 2007(381):pe14.
37. Leeper D.B., Engin K., Thistlethwaite A.J., Hitchon H.D., Dover J.D., Li D.J. Human tumor extracellular pH as a function of blood glucose concentration. Int J Radiat Oncol Biol Phys 1994, 28(4):935-943.
38. Volk T., Jähde E., Fortmeyer H.P., Glüsenkamp K.H., Rajewsky M.F. pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer 1993, 68(3):492-500.
39. Abdelrahim M., Konduri S., Basha R., Philip P.A., Baker C.H. Angiogenesis: an update and potential drug approaches (review). Int J Oncol 2010, 36(1):5-18.
40. Tozer G.M., Kanthou C., Baguley B.C. Disrupting tumour blood vessels. Nat Rev Cancer 2005, 5(6):423-435.
41. Neri D., Bicknell R. Tumour vascular targeting. Nat Rev Cancer 2005, 5(6):436-446.
42. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307(5706):58-62.
43. Bode C., Trojan L., Weiss C., Kraenzlin B., Michaelis U., Teifel M., et al. Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer. Oncol Rep 2009, 22(2):321-326.
44. Abu-Lila A., Suzuki T., Doi Y., Ishida T., Kiwada H. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model. JControl Release 2009, 134(1):18-25.
45. Ran S., Downes A., Thorpe P.E. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002, 62(21):6132-6140.
46. Makovitzki A., Fink A., Shai Y. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Cancer Res 2009, 69(8):3458-3463.
47. von Ardenne M. Principles and 1977 concept of cancer multistep therapy. Physiological fundamentals of the new timing. Selectotherm local hyperthermy. Arch Geschwulstforsch 1978, 48(6):504-520.
48. Lee E.S., Na K., Bae Y.H. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. JControl Release 2005, 103(2):405-418.
49. Gillies E.R., Fréchet J.M. pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug Chem 2005, 16(2):361-368.
50. Drummond D.C., Zignani M., Leroux J. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 2000, 39(5):409-460.
51. Lynn D.M., Amiji M.M., Langer R. pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular pH. Angew Chem Int Ed Engl 2001, 40(9):1707-1710.